Introduction
Oesophageal carcinoma, accounting for approximately 10 deaths per 100,000 people annually, is a major health problem in the United Kingdom.' With many patients presenting with disseminated disease, either manifest or occult, curative treatment is applicable to only a small minority. For the majority of patients palliative relief of dysphagia is the goal of treatment.
Clinicians have an ever increasing armamentarium of palliative techniques to choose from but no single treatment modality has emerged as clearly superior to all others. The ideal palliative therapy would restore normal deglutition while avoiding prolonged hospitalization, repetitive treatments, and significant morbidity and mortality. Palliative treatment options include surgical resection, surgical bypass, radiotherapy, brachytherapy, dilatation, intubation, laser therapy, electrocoagulation, and chemoradiotherapy. '-4 Although many consider surgical resection to be the palliative procedure of choice for carcinoma of the oesophagus,`7 a large group of patients are unsuitable for resection because of advanced disease or poor general health. 8 Complications include perforation (7%), tube migration (23%), tube obstruction (6%), inability to intubate (5%), pressure necrosis (3%) and bleeding (1%).'3 Since a 'tube diet' must be prescribed, the palliation is far from complete when compared to the palliative results of surgical resection. 10, 16 Widespread availability, low cost, and endoscopic palliation in a single session are some of the advantages of intubation. It remains the palliative method of choice for many patients. '5 Laser therapy NdYAG laser therapy has been shown to be both safe and effective, with a mortality of 1% and a success rate of 83% in a large collective series.'7 Tracheo-bronchial fistulization is an indication for intubation, the success of treatment being dependent upon the anatomy of the lesion." If the fistula is situated distally within a malignant stricture intubation may be quite successful.'3 Fistulae proximal to a stricture present a far greater challenge. Specially modified prostheses have proved useful in some of these patients but palliation is generally poor.25-27 Failed intubation of a malignant fistula is the only current indication for surgical bypass. '6 An unfortunate group of patients are poorly palliated by either laser or intubation. Markedly angulated lesions and tumours at the very proximal and distal oesophagus may be difficult' to palliate by either method. The complication rate of both techniques is higher for markedly angulated lesions but success is still attainable by skilled operators using either method. 3 Two prospective trials are available for review. In a small prospective randomized study of 20 patients superior palliation with fewer complications was reported in the laser treated group.29 A trend towards increased survival in the laser group was an unexpected finding. In the second study, 40 patients were randomized to laser treatment alone or laser therapy followed by intubation.20 Palliation of dysphagia and quality of life assessments were similar for the two groups. There was no procedure related mortality. Although the complication rate ofthe laser-intubation group (40%) was significantly higher than the laser alone group (10%), most of the intubation-related morbidity was due to food bolus obstruction ofthe prostheses and was amenable to endoscopic clearing of the tubes.
While oesophageal cancer remains an all too frequent neoplasm, with curative strategies still elusive, patients are not well served by therapeutic nihilism. Effective palliation is the major objective in the care of these unfortunate patients. This is best achieved by an individualized approach to each patient. Although laser and intubation methods initially seem competitive, their unique properties and complementary nature become apparent with increasing experience.
